AHMA exhibits a strong Piotroski F-Score of 7/9, indicating solid operational health and improving profitability, but lacks an Altman Z-Score, which raises concern about financial distress risk. The stock trades at a steep valuation with a P/E of 129.50—far above the sector average of 43.00—despite modest revenue growth and a recent 190.9% earnings surge that may be unsustainable. The Graham Number of $0.46 and intrinsic value of $1.18 suggest deep undervaluation, yet the current price of $5.18 reflects a premium driven by speculative growth expectations. Technical trends are bearish, and insider sentiment is neutral, with no dividend history. Overall, the stock appears overvalued relative to fundamentals and carries high risk despite strong profitability metrics.